66
Participants
Start Date
July 31, 2015
Primary Completion Date
May 31, 2017
Study Completion Date
June 30, 2017
ODM-109
ODM-109 1 mg capsule for oral administration.
Placebo for ODM-109
Placebo capsule for oral administration.
Charite Universitatsmedizin Berlin, Berlin
Medical School Hannover, Hanover
University Clinical Jena, Jena
University Hospital of Ulm, Ulm
Beaumont Hospital, Dublin
University Medical Centre Utrecht, Utrecht
Royal Sussex County Hospital, Brighton
The Walton Centre, Liverpool
London Kings College Hospital, London
Royal London Hospital, London
University of Sheffield, Sheffield
Orion Corporation, Orion Pharma
INDUSTRY